. . . . . . . . . . . . . . "a(CHEBI:rosiglitazone) -| p(HGNC:CRP)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "the PPARG agonist rosiglitazone has been found to reduce serum concentrations of CRP and inflammatory cytokines in markers of cardiovascular disease in patients with type 2 diabetes mellitus (97)" . . "Selventa" . . . . "2014-07-03T14:32:52.619+02:00"^^ . . .